Fig. 2
From: Robust RNA-based in situ mutation detection delineates colorectal cancer subclonal evolution
Validation of BaseScope probes in tumors. Representative images of the validation of the KRAS G12D probeset a and BRAF V600E probeset b in archival human tumor tissue. In both cases a wild-type tumor and a mutant tumor are shown, with a negative control probe (dapB), a positive control probe (POLR2A), the wild-type probe and the mutant probe. Scale bars represent 50 micron and 10 micron (inset)
